ANI Pharmaceuticals Inc. News
3 Biotech Stocks I Love for March (Celgene Is One of Them)
These biotech names are all great buys on dips. Notably Celgene, which is fresh off a terrible trading session.
5 stocks poised for major breakouts
These stocks are within range of triggering breakout trades. Here's how to trade them from here.
ANI Pharmaceuticals' varied offerings, strategic acquisitions make it a good play for investors
The Baudette, Minn.-based company has 79 products generating about $4 billion in sales and a number of other promising therapies in its pipeline.
Strong On High Relative Volume: ANI Pharmaceuticals (ANIP)
Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a strong on high relative volume candidate
Perilous Reversal Watch: ANI Pharmaceuticals (ANIP)
Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a "perilous reversal" (up big yesterday but down big today) candidate
Today's Dead Cat Bounce Stock Is ANI Pharmaceuticals (ANIP)
Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a "dead cat bounce" (down big yesterday but up big today) candidate
ANI Pharmaceuticals (ANIP) Marked As A Dead Cat Bounce Stock
Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a "dead cat bounce" (down big yesterday but up big today) candidate
Stock To Watch: ANI Pharmaceuticals (ANIP) In Perilous Reversal
Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a "perilous reversal" (up big yesterday but down big today) candidate
Trade-Ideas: ANI Pharmaceuticals (ANIP) Is Today's "Dead Cat Bounce" Stock
Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a "dead cat bounce" (down big yesterday but up big today) candidate
Today's Perilous Reversal Stock: ANI Pharmaceuticals (ANIP)
Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a "perilous reversal" (up big yesterday but down big today) candidate
Breaking News
UnitedHealth Group Stock Edges Lower On Muted 2023 Profit Forecast
UnitedHealth, a Dow component, will host it annual investor event later today in New York.
Roku Stock Slides As KeyBanc Cuts Rating to 'Sector Weight' On Ad Weakness
Roku's eroding market share, and its need for new investment, will pressure near-term profits, according to KeyBanc analyst Justin Patterson.
Tesla Sentiment, Fundamentals Affected By Musk's Twitter Purchase - Morgan Stanley Survey
“Our investor survey reinforces our views that Elon Musk's recent involvement with Twitter has contributed to negative sentiment momentum in Tesla shares," said Morgan Stanley analyst Adam Jonas.
T-Mobile Adds a Fee That Feels Like an AT&T or Verizon Move
Mobile carrier companies are always eager to increase revenue through fees customers pay and to outflank their competition with deals.